Cardiovascular disease (CVD) prevention programme

Improving the detection and management of the high-risk conditions – Atrial Fibrillation (AF), high blood pressure and high cholesterol as well as early diagnosis of Familial Hypercholesterolaemia (FH). 

Lipid management and Familial Hypercholesterolaemia (FH)

The AHSNs are delivering a national programme of work around cardiovascular disease (CVD) prevention.

The aim of this programme will be to support primary care in the prevention and management of CVD, introducing targeted interventions for people with high cholesterol, including identifying and treating people with familial hypercholesterolaemia, with further regional activity focusing on atrial fibrillation (AF) and high blood pressure.

This is a national AHSN Network adoption and spread initiative. 

Listen to the podcast

AHSN Health Innovation Podcast - familial hypercholesterolaemia
How a heart attack saved a young mum's life
A 34-year old woman in Carlisle, Ciara Wannop, didn’t know she had familial hypercholesterolaemia until she had a heart attack while 26 weeks’ pregnant. She feels lucky to have had an early warning of a potentially life-limiting condition. Listen to this episode of the AHSN Network Health Innovation Podcast

Find out more

The AHSNs are scoping a national programme of work around cardiovascular disease (CVD) prevention, which we anticipate will start in autumn 2020. Click here for the latest from the AHSN Network on this programme.

Nick Clarke Eastern AHSN
Get in touch

If you want to learn more about the rollout of this intervention in the east please contact [email protected]

programmesDr Mike Knapton, Clinical Advisor at Eastern AHSN
Putting cardiovascular disease at the heart of health services

Dr Mike Knapton, Clinical Advisor at Eastern AHSN, highlights our work to improve heart health in our region. Mike is a Non-Executive Director of Cambridge University Hospitals NHS Foundation Trust and was a local GP.

Read the full story…

Related work

Find out about our work in the east supporting best practice in the screening and treatment of atrial fibrillation.

Read more

Heart atrial fibrillation
Reducing the impact of COVID-19 on Atrial Fibrillation detection and treatment

Read this AHSN Network blog by Helen Williams, Consultant Pharmacist here.

Share your idea

Do you have a great idea that could make a positive health impact?

Get involved

Newsletter